SRPT · Sarepta Therapeutics, Inc. · Documents
$19.17
+1.44 (+8.12%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.87B
Shares
105.63M
Volume · Oct 20
3.33M
Avg daily vol (3M)
3.1M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-03-03 | 2023-03-02 | |
| 10-K | — | 2023-02-28 | 2022-12-31 | |
| 8-K | — | 2023-01-09 | — | |
| 8-K | — | 2022-12-13 | 2022-12-09 | |
| 10-Q | — | 2022-11-02 | 2022-09-30 | |
| 8-K | — | 2022-11-02 | 2022-10-31 | |
| 8-K | — | 2022-09-19 | 2022-09-13 | |
| 10-Q | — | 2022-08-02 | 2022-06-30 | |
| 8-K | — | 2022-06-03 | 2022-06-02 | |
| 10-Q | — | 2022-05-04 | 2022-03-31 | |
| DEF 14A | — | 2022-04-25 | 2022-06-02 | |
| 8-K | — | 2022-04-21 | 2022-04-19 | |
| 8-K | — | 2022-04-05 | 2022-03-31 | |
| 10-K | — | 2022-03-01 | 2021-12-31 | |
| 8-K | — | 2022-01-10 | — | |
| 8-K | — | 2021-11-17 | 2021-11-15 | |
| 10-Q | — | 2021-11-03 | 2021-09-30 | |
| 8-K | — | 2021-10-15 | 2021-10-12 | |
| 8-K | — | 2021-09-27 | — | |
| 10-Q | — | 2021-08-04 | 2021-06-30 | |
| 8-K | — | 2021-06-03 | — | |
| 8-K | — | 2021-05-18 | — | |
| 10-Q | — | 2021-05-05 | 2021-03-31 | |
| 8-K | — | 2021-05-03 | — | |
| DEF 14A | — | 2021-04-20 | 2021-06-03 | |
| 10-K | — | 2021-03-01 | 2020-12-31 | |
| 8-K | — | 2021-01-11 | — | |
| 8-K | — | 2021-01-07 | — | |
| 8-K | — | 2020-12-14 | 2020-12-08 | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-09-25 | 2020-09-24 | |
| 8-K | — | 2020-09-09 | — | |
| 10-Q | — | 2020-08-05 | 2020-06-30 | |
| 8-K | — | 2020-08-05 | 2020-08-03 | |
| 8-K | — | 2020-06-30 | 2020-06-26 | |
| 8-K | — | 2020-06-08 | 2020-06-04 | |
| 8-K | — | 2020-06-08 | — | |
| 10-Q | — | 2020-05-06 | 2020-03-31 | |
| DEF 14A | — | 2020-04-21 | 2020-06-04 | |
| 8-K | — | 2020-03-19 | 2020-03-18 | |
| 10-K | — | 2020-02-26 | 2019-12-31 | |
| 8-K | — | 2020-02-21 | 2020-02-19 | |
| 8-K | — | 2020-02-18 | 2020-02-14 | |
| 8-K | — | 2020-01-13 | — | |
| 8-K | — | 2020-01-13 | 2020-01-08 |
Showing 51–95 of 95 filings
Key facts
CIK
873303
CUSIP
803607100
13F (30d)
27 filings
26 filers
Visit website
Investor relations